Kmart Agrees to Pay $32.3 million to Settle Whistle Blower’s False Claims Act Suit
The Health Law Firm
FEBRUARY 20, 2018
million to settle a whistle blower lawsuit alleging its pharmacies caused federal health programs to overpay for prescription drugs by not telling the government about discounted prices. The new agreement resolves allegations arising from a 2008 lawsuit brought under the qui tam, or whistle blower, provisions of the False Claims Act (FCA).
Let's personalize your content